Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations
Human epidermal growth factor receptor 2 (HER2) is a member of the HER family of proteins containing four receptor tyrosine kinases. It plays an important role in the pathogenesis of certain human cancers. In non‐small‐cell lung cancer (NSCLC), HER2 amplification or mutations have been reported. How...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724821/ |